Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Drugs, Chinese Herbal | 4 | 2021 | 151 | 2.110 |
Why?
|
Medicine, Kampo | 3 | 2021 | 4 | 1.650 |
Why?
|
Anemia, Aplastic | 9 | 2021 | 228 | 1.460 |
Why?
|
Bone Marrow Diseases | 3 | 2023 | 233 | 1.060 |
Why?
|
Cystitis | 2 | 2014 | 96 | 0.870 |
Why?
|
Graft vs Host Disease | 7 | 2023 | 3022 | 0.840 |
Why?
|
Dyskeratosis Congenita | 1 | 2023 | 73 | 0.840 |
Why?
|
Lipomatosis | 1 | 2023 | 112 | 0.830 |
Why?
|
Exocrine Pancreatic Insufficiency | 1 | 2023 | 84 | 0.830 |
Why?
|
Hematopoietic Stem Cell Transplantation | 9 | 2023 | 5630 | 0.800 |
Why?
|
Plakins | 1 | 2021 | 4 | 0.780 |
Why?
|
Hematologic Diseases | 2 | 2023 | 497 | 0.780 |
Why?
|
Pulmonary Veno-Occlusive Disease | 1 | 2021 | 64 | 0.750 |
Why?
|
Crying | 1 | 2021 | 37 | 0.730 |
Why?
|
Parasomnias | 1 | 2021 | 27 | 0.730 |
Why?
|
Pancytopenia | 2 | 2023 | 101 | 0.650 |
Why?
|
Alopecia Areata | 1 | 2021 | 127 | 0.630 |
Why?
|
Mycophenolic Acid | 1 | 2019 | 343 | 0.550 |
Why?
|
Acupuncture Therapy | 1 | 2021 | 480 | 0.550 |
Why?
|
Hypertension, Pulmonary | 2 | 2021 | 1567 | 0.550 |
Why?
|
Hematuria | 2 | 2014 | 233 | 0.530 |
Why?
|
Leukemia, Myelomonocytic, Juvenile | 3 | 2021 | 25 | 0.530 |
Why?
|
Core Binding Factor Alpha 2 Subunit | 2 | 2023 | 352 | 0.520 |
Why?
|
Adenovirus Infections, Human | 1 | 2015 | 73 | 0.490 |
Why?
|
Aldehyde Dehydrogenase | 1 | 2014 | 147 | 0.450 |
Why?
|
Hepatitis | 1 | 2015 | 231 | 0.440 |
Why?
|
Autoantibodies | 1 | 2021 | 2116 | 0.410 |
Why?
|
Fusarium | 1 | 2012 | 51 | 0.410 |
Why?
|
Hemoglobinuria, Paroxysmal | 3 | 2017 | 95 | 0.390 |
Why?
|
Epoprostenol | 1 | 2012 | 248 | 0.390 |
Why?
|
Lung Transplantation | 1 | 2021 | 1301 | 0.390 |
Why?
|
Tumor Virus Infections | 1 | 2014 | 438 | 0.390 |
Why?
|
DNA, Viral | 2 | 2015 | 2195 | 0.390 |
Why?
|
Viremia | 1 | 2014 | 708 | 0.380 |
Why?
|
Adenoviridae | 1 | 2015 | 1084 | 0.380 |
Why?
|
Phytotherapy | 1 | 2012 | 295 | 0.350 |
Why?
|
Sulfones | 1 | 2012 | 447 | 0.350 |
Why?
|
Hematologic Neoplasms | 3 | 2019 | 1898 | 0.340 |
Why?
|
Antilymphocyte Serum | 3 | 2023 | 482 | 0.330 |
Why?
|
Cytokines | 1 | 2023 | 7346 | 0.310 |
Why?
|
Vasodilator Agents | 1 | 2012 | 976 | 0.310 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2016 | 1524 | 0.290 |
Why?
|
Eosinophilia | 1 | 2012 | 560 | 0.290 |
Why?
|
Antifungal Agents | 1 | 2012 | 745 | 0.290 |
Why?
|
Child | 28 | 2023 | 79623 | 0.290 |
Why?
|
Japan | 5 | 2020 | 1367 | 0.280 |
Why?
|
Bone Marrow | 2 | 2014 | 2918 | 0.280 |
Why?
|
Arthritis | 1 | 2012 | 666 | 0.280 |
Why?
|
Triazoles | 1 | 2012 | 905 | 0.280 |
Why?
|
Infant | 19 | 2021 | 35941 | 0.270 |
Why?
|
Cord Blood Stem Cell Transplantation | 3 | 2021 | 305 | 0.270 |
Why?
|
Urinary Bladder | 1 | 2012 | 1165 | 0.260 |
Why?
|
Antiviral Agents | 2 | 2015 | 3060 | 0.250 |
Why?
|
Pyrimidines | 2 | 2021 | 2996 | 0.250 |
Why?
|
Child, Preschool | 19 | 2022 | 41935 | 0.250 |
Why?
|
Leukemia | 1 | 2012 | 1511 | 0.240 |
Why?
|
Child, Hospitalized | 2 | 2023 | 178 | 0.230 |
Why?
|
Signal Recognition Particle | 1 | 2023 | 47 | 0.230 |
Why?
|
Polymorphism, Genetic | 1 | 2014 | 4286 | 0.230 |
Why?
|
Registries | 2 | 2019 | 8434 | 0.210 |
Why?
|
Repressor Proteins | 2 | 2016 | 2981 | 0.200 |
Why?
|
Piperazines | 1 | 2012 | 2517 | 0.200 |
Why?
|
Adolescent | 19 | 2021 | 87560 | 0.200 |
Why?
|
Tumor Suppressor Proteins | 1 | 2012 | 2804 | 0.190 |
Why?
|
Bone Marrow Transplantation | 3 | 2023 | 2696 | 0.190 |
Why?
|
Telomere | 3 | 2021 | 934 | 0.190 |
Why?
|
Hospitalization | 1 | 2021 | 10734 | 0.180 |
Why?
|
Janus Kinase 3 | 1 | 2020 | 77 | 0.170 |
Why?
|
Hemorrhage | 1 | 2012 | 3606 | 0.170 |
Why?
|
Polymerase Chain Reaction | 2 | 2020 | 6070 | 0.170 |
Why?
|
Transplantation Conditioning | 3 | 2022 | 1593 | 0.170 |
Why?
|
Interferon-alpha | 1 | 2023 | 918 | 0.160 |
Why?
|
Catheter-Related Infections | 1 | 2022 | 272 | 0.160 |
Why?
|
Oncogene Proteins, Fusion | 2 | 2018 | 1588 | 0.160 |
Why?
|
Humans | 46 | 2023 | 759255 | 0.160 |
Why?
|
Anemia, Dyserythropoietic, Congenital | 1 | 2018 | 15 | 0.160 |
Why?
|
Mutation | 7 | 2023 | 29877 | 0.160 |
Why?
|
Catheterization, Peripheral | 1 | 2022 | 343 | 0.160 |
Why?
|
Cysteine Endopeptidases | 1 | 2021 | 548 | 0.150 |
Why?
|
Neoplasms | 3 | 2023 | 22019 | 0.150 |
Why?
|
Dermatan Sulfate | 1 | 2017 | 43 | 0.150 |
Why?
|
Aneurysm, Infected | 1 | 2018 | 81 | 0.150 |
Why?
|
Thrombosis | 1 | 2012 | 3043 | 0.150 |
Why?
|
Anemia, Hemolytic, Congenital | 1 | 2018 | 71 | 0.150 |
Why?
|
Chondroitin Sulfates | 1 | 2017 | 175 | 0.150 |
Why?
|
Catheterization, Central Venous | 1 | 2022 | 526 | 0.140 |
Why?
|
Pericarditis | 1 | 2018 | 136 | 0.140 |
Why?
|
Immunosuppressive Agents | 3 | 2021 | 4168 | 0.140 |
Why?
|
Heparitin Sulfate | 1 | 2017 | 224 | 0.140 |
Why?
|
Neutropenia | 1 | 2022 | 884 | 0.140 |
Why?
|
Transplantation, Homologous | 4 | 2023 | 4799 | 0.140 |
Why?
|
Pericardial Effusion | 1 | 2018 | 247 | 0.140 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2012 | 3605 | 0.130 |
Why?
|
Invasive Pulmonary Aspergillosis | 1 | 2015 | 17 | 0.130 |
Why?
|
Viral Load | 2 | 2015 | 3317 | 0.130 |
Why?
|
Interleukin Receptor Common gamma Subunit | 1 | 2015 | 85 | 0.130 |
Why?
|
Aspergillus | 1 | 2015 | 92 | 0.130 |
Why?
|
Male | 26 | 2021 | 358719 | 0.120 |
Why?
|
Calreticulin | 1 | 2016 | 115 | 0.120 |
Why?
|
Myelodysplastic Syndromes | 2 | 2015 | 1395 | 0.120 |
Why?
|
Thrombocythemia, Essential | 1 | 2016 | 107 | 0.120 |
Why?
|
Medicine, East Asian Traditional | 1 | 2014 | 18 | 0.120 |
Why?
|
Echocardiography | 2 | 2021 | 4971 | 0.120 |
Why?
|
Receptors, Thrombopoietin | 1 | 2016 | 161 | 0.120 |
Why?
|
GATA2 Transcription Factor | 1 | 2015 | 158 | 0.120 |
Why?
|
DNA, Neoplasm | 2 | 2018 | 1744 | 0.120 |
Why?
|
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2016 | 223 | 0.120 |
Why?
|
DNA Transposable Elements | 1 | 2018 | 752 | 0.120 |
Why?
|
DiGeorge Syndrome | 1 | 2016 | 186 | 0.120 |
Why?
|
Mutation, Missense | 2 | 2021 | 2559 | 0.110 |
Why?
|
BK Virus | 1 | 2014 | 125 | 0.110 |
Why?
|
Neuroblastoma | 1 | 2022 | 1252 | 0.110 |
Why?
|
Thrombopoietin | 1 | 2015 | 226 | 0.110 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2023 | 2867 | 0.110 |
Why?
|
Janus Kinase 2 | 1 | 2016 | 541 | 0.110 |
Why?
|
Retrospective Studies | 11 | 2023 | 80121 | 0.100 |
Why?
|
Piperidines | 1 | 2021 | 1649 | 0.100 |
Why?
|
Natural Killer T-Cells | 1 | 2015 | 309 | 0.100 |
Why?
|
Aortic Aneurysm, Thoracic | 1 | 2018 | 693 | 0.100 |
Why?
|
Immunologic Deficiency Syndromes | 1 | 2015 | 556 | 0.100 |
Why?
|
Chromosomes, Human, Pair 21 | 1 | 2012 | 228 | 0.100 |
Why?
|
Neoplasm, Residual | 1 | 2016 | 1007 | 0.100 |
Why?
|
Histocytochemistry | 1 | 2012 | 693 | 0.090 |
Why?
|
Injections, Intra-Articular | 1 | 2012 | 280 | 0.090 |
Why?
|
Cytomegalovirus | 1 | 2015 | 757 | 0.090 |
Why?
|
Hematopoiesis | 1 | 2020 | 2063 | 0.090 |
Why?
|
Chromosomes, Human, Pair 16 | 1 | 2012 | 342 | 0.090 |
Why?
|
T-Lymphocytes | 2 | 2018 | 10181 | 0.080 |
Why?
|
Purpura, Thrombocytopenic, Idiopathic | 1 | 2014 | 240 | 0.080 |
Why?
|
Female | 21 | 2021 | 390240 | 0.080 |
Why?
|
Fetal Blood | 1 | 2016 | 1339 | 0.080 |
Why?
|
Interleukin-17 | 1 | 2015 | 908 | 0.080 |
Why?
|
Virus Diseases | 1 | 2015 | 722 | 0.080 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2014 | 664 | 0.080 |
Why?
|
Purines | 1 | 2012 | 601 | 0.080 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2018 | 2535 | 0.080 |
Why?
|
Combined Modality Therapy | 1 | 2021 | 8549 | 0.080 |
Why?
|
Stem Cell Transplantation | 1 | 2017 | 1603 | 0.080 |
Why?
|
Myeloproliferative Disorders | 1 | 2015 | 610 | 0.080 |
Why?
|
Autoimmune Diseases | 1 | 2021 | 2250 | 0.080 |
Why?
|
Genetic Testing | 2 | 2018 | 3531 | 0.080 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2018 | 3615 | 0.070 |
Why?
|
Infant, Newborn | 5 | 2021 | 26109 | 0.070 |
Why?
|
Microscopy | 1 | 2012 | 880 | 0.070 |
Why?
|
Immunocompromised Host | 1 | 2012 | 857 | 0.070 |
Why?
|
Carrier Proteins | 1 | 2020 | 4939 | 0.070 |
Why?
|
Translocation, Genetic | 1 | 2012 | 1388 | 0.070 |
Why?
|
Lymphocytes | 1 | 2014 | 2609 | 0.070 |
Why?
|
Chronic Disease | 1 | 2021 | 9282 | 0.070 |
Why?
|
Treatment Outcome | 8 | 2021 | 64879 | 0.070 |
Why?
|
Nuclear Proteins | 1 | 2020 | 5793 | 0.060 |
Why?
|
Drug-Eluting Stents | 1 | 2011 | 758 | 0.060 |
Why?
|
Sirolimus | 1 | 2011 | 1548 | 0.060 |
Why?
|
Paclitaxel | 1 | 2011 | 1715 | 0.060 |
Why?
|
Neoplasm Proteins | 1 | 2016 | 3613 | 0.060 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2011 | 1880 | 0.060 |
Why?
|
Glomerular Filtration Rate | 1 | 2012 | 2168 | 0.050 |
Why?
|
Lung | 1 | 2021 | 9982 | 0.050 |
Why?
|
Leukocyte Count | 2 | 2018 | 1599 | 0.050 |
Why?
|
Risk Assessment | 2 | 2021 | 24049 | 0.050 |
Why?
|
Graft Rejection | 1 | 2015 | 4418 | 0.050 |
Why?
|
Cell Proliferation | 1 | 2018 | 10440 | 0.050 |
Why?
|
Anticoagulants | 1 | 2017 | 4897 | 0.050 |
Why?
|
Gene Expression Profiling | 1 | 2018 | 9374 | 0.050 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2015 | 4545 | 0.050 |
Why?
|
Protein Kinase Inhibitors | 1 | 2018 | 5635 | 0.050 |
Why?
|
Myocardial Ischemia | 1 | 2011 | 2161 | 0.050 |
Why?
|
Disease Progression | 2 | 2014 | 13479 | 0.040 |
Why?
|
Etoposide | 1 | 2022 | 628 | 0.040 |
Why?
|
Melphalan | 1 | 2022 | 421 | 0.040 |
Why?
|
DNA Mutational Analysis | 2 | 2020 | 4111 | 0.040 |
Why?
|
Suppuration | 1 | 2018 | 61 | 0.040 |
Why?
|
Lymphocyte Count | 1 | 2021 | 779 | 0.040 |
Why?
|
Germ Cells | 1 | 2023 | 635 | 0.040 |
Why?
|
Prognosis | 5 | 2021 | 29561 | 0.040 |
Why?
|
Carboplatin | 1 | 2022 | 789 | 0.040 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2023 | 1446 | 0.040 |
Why?
|
Skin | 1 | 2012 | 4467 | 0.040 |
Why?
|
Camptothecin | 1 | 2022 | 588 | 0.040 |
Why?
|
Prospective Studies | 1 | 2023 | 54204 | 0.040 |
Why?
|
Pedigree | 2 | 2015 | 4572 | 0.040 |
Why?
|
HLA Antigens | 1 | 2023 | 1366 | 0.040 |
Why?
|
Diagnosis, Differential | 3 | 2018 | 12964 | 0.040 |
Why?
|
Bone Marrow Examination | 1 | 2016 | 156 | 0.030 |
Why?
|
Amino Acid Substitution | 1 | 2021 | 1737 | 0.030 |
Why?
|
Time Factors | 2 | 2016 | 40109 | 0.030 |
Why?
|
Immunophenotyping | 1 | 2021 | 1870 | 0.030 |
Why?
|
Creatinine | 1 | 2022 | 1907 | 0.030 |
Why?
|
Risk Factors | 6 | 2022 | 74167 | 0.030 |
Why?
|
Retroviridae | 1 | 2018 | 851 | 0.030 |
Why?
|
DNA Methylation | 2 | 2021 | 4371 | 0.030 |
Why?
|
Sequence Analysis, DNA | 2 | 2017 | 4716 | 0.030 |
Why?
|
Follow-Up Studies | 4 | 2020 | 39216 | 0.030 |
Why?
|
Lentivirus | 1 | 2018 | 504 | 0.030 |
Why?
|
Germ-Line Mutation | 1 | 2023 | 1843 | 0.030 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2016 | 717 | 0.030 |
Why?
|
RNA, Neoplasm | 1 | 2016 | 748 | 0.030 |
Why?
|
Hydroxamic Acids | 1 | 2016 | 482 | 0.030 |
Why?
|
ROC Curve | 1 | 2021 | 3570 | 0.030 |
Why?
|
Streptococcus pneumoniae | 1 | 2018 | 732 | 0.030 |
Why?
|
Drainage | 1 | 2018 | 1157 | 0.030 |
Why?
|
Survival Rate | 2 | 2020 | 12800 | 0.030 |
Why?
|
Aorta, Thoracic | 1 | 2018 | 1094 | 0.030 |
Why?
|
Mosaicism | 1 | 2015 | 466 | 0.030 |
Why?
|
Adult | 3 | 2021 | 219390 | 0.020 |
Why?
|
Histone Deacetylases | 1 | 2016 | 718 | 0.020 |
Why?
|
Platelet Count | 1 | 2014 | 776 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2022 | 9269 | 0.020 |
Why?
|
Fatal Outcome | 1 | 2015 | 1833 | 0.020 |
Why?
|
Myocardial Infarction | 1 | 2012 | 11888 | 0.020 |
Why?
|
Disease Management | 1 | 2021 | 2498 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2012 | 20461 | 0.020 |
Why?
|
Rabbits | 1 | 2015 | 4772 | 0.020 |
Why?
|
Dexamethasone | 1 | 2016 | 1927 | 0.020 |
Why?
|
Antineoplastic Agents | 1 | 2012 | 13621 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2016 | 6131 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2016 | 1993 | 0.020 |
Why?
|
Young Adult | 3 | 2021 | 58483 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 3804 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2016 | 4262 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2018 | 3823 | 0.020 |
Why?
|
Comorbidity | 1 | 2021 | 10547 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2016 | 6813 | 0.020 |
Why?
|
Tissue Donors | 1 | 2015 | 2301 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2015 | 2712 | 0.020 |
Why?
|
Cross-Over Studies | 1 | 2011 | 2058 | 0.020 |
Why?
|
Survival Analysis | 1 | 2017 | 10185 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2016 | 2803 | 0.020 |
Why?
|
Family | 1 | 2015 | 3189 | 0.010 |
Why?
|
Aged | 4 | 2021 | 168617 | 0.010 |
Why?
|
Recurrence | 1 | 2015 | 8469 | 0.010 |
Why?
|
B-Lymphocytes | 1 | 2016 | 4733 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2021 | 15815 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2015 | 12152 | 0.010 |
Why?
|
Incidence | 1 | 2020 | 21336 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2022 | 11653 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2017 | 7851 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2018 | 7380 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2016 | 16871 | 0.010 |
Why?
|
Risk | 1 | 2012 | 9623 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2018 | 12580 | 0.010 |
Why?
|
Age Factors | 1 | 2015 | 18394 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2014 | 15264 | 0.010 |
Why?
|
Hospital Mortality | 1 | 2012 | 5414 | 0.010 |
Why?
|
Middle Aged | 3 | 2021 | 219653 | 0.010 |
Why?
|
Transcription Factors | 1 | 2016 | 12106 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2015 | 17750 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2012 | 58867 | 0.000 |
Why?
|
Animals | 1 | 2015 | 167838 | 0.000 |
Why?
|